#USA #New York #Aily Labs #Amy Chang #Joseph Jimenez

Aily Labs Expands Leadership to Accelerate AI Adoption

Aily Labs, known for its groundbreaking AI-native Decision Intelligence App, has recently announced the appointment of three influential figures to its leadership roster. This strategic move aims to drive agentic AI adoption within Fortune 500 firms, fostering innovation and efficient decision-making processes.

Amy Chang Joins the Board

First up is Amy Chang, a recognized technology leader who currently serves on the boards of both Disney and Procter & Gamble. With credentials that include founding Accompany, now part of Cisco, Chang's experience spans digital transformation and high-growth tech innovations. Her role at Aily Labs is critical, as the company accelerates its mission to transition traditional business decisions into an active, AI-driven framework.

In her own words, "This is an incredibly exciting time to be advising Aily Labs... their vision to shift enterprises from passive data to active, agent-driven action is bold." Her notable past contributions to companies like Cisco and Splunk underscore her expertise in scaling tech solutions in large corporations, making her insights invaluable for Aily Labs.

Joseph Jimenez's Healthcare Expertise

Next, Joseph Jimenez joins the Advisory Board, bringing with him extensive experience from the healthcare sector. He is not only the Co-Founder and Managing Director of Aditum Bio but also a former CEO of Novartis, where he streamlined business decisions across multiple divisions.

Jimenez emphasizes the urgency that AI can provide in decision-making, particularly in sectors like pharmaceuticals, where timely information can save lives. His vision aligns perfectly with Aily Labs' objective to automate decision processes through agentic AI, making it a vital platform for leadership teams requiring precise and fast outcomes.

Derica Rice's Financial Acumen

Completing the trio is Derica Rice, the former EVP of CVS Health and the President of CVS Caremark. Rice brings a wealth of financial and healthcare experience, having shaped corporate strategies at Eli Lilly as its former CFO. His insights into the healthcare and consumer packaged goods sectors are crucial as Aily Labs pushes for AI integration across industries.

His perspectives on productivity enhancement through AI—enabling seamless work between human and AI agents—speak to Aily Labs' goal of minimizing inefficiencies and accelerating decision-making capabilities.

A Vision for the Future

Bianca Anghelina, the founder and CEO of Aily Labs, expressed her excitement about these appointments, stating, "Together, we're not just augmenting decisions; we're reshaping how the world's most influential companies apply AI at scale for decision-making."
Aily Labs’ innovative platform combines advanced AI technologies with real-time business data, providing actionable insights designed to improve efficiency and drive growth in major organizations.

Founded in 2020, Aily Labs has quickly become a key player in AI solutions for businesses, with the aim of integrating AI into their workflows effectively. With its robust leadership team, the company is set to revolutionize how businesses function in an increasingly AI-driven world.

For those keen on exploring AI's transformative potential, Aily Labs stands as a beacon for forward-thinking enterprises ready to harness the power of agentic AI. Their journey is just beginning, and the possibilities for AI in the corporate landscape are vast and promising.

For more information, visit ailylabs.com.